Congenital Diaphragmatic Hernia, Delayed Umbilical Cord Separation, Umbilical Cord Clamping
Conditions
Brief summary
Congenital diaphragmatic hernia (CDH) is a malformation that affects 1 in every 3000 newborns. The diaphragm does not complete its closure during embryogenesis, which allows the abdominal organs to herniate into the thoracic cavity altering lung development. The lungs of patients with CDH are small, with a decreased surface area for gas exchange and developmental impair of the pulmonary vasculature, resulting in respiratory failure and pulmonary hypertension shortly after birth. When clamping the umbilical cord, a large part of the preload is abruptly excluded, generating an increase in vascular resistance, which in turn increase the afterload, resulting in a decrease in cardiac output. The output is restored by decreasing vascular resistance in pulmonary circuit after lung aeration upon receiving the preload of the right atrium, increasing pulmonary flow and thus sustaining the preload of the left ventricle. If pulmonary aeration occurs before clamping the umbilical cord, the pulmonary blood flow increases before placenta flow is lost, thus avoiding a decrease in cardiac output. This modality has been called physiological base cord clamping (PFC). The hypothesis is that PFC once ventilation has been established could prevent hypoxia and improve cardiac output in newborns with CDH and secondarily improve their hemodynamic parameters, stabilizing gas exchange and pulmonary hypertension during the first 24 hours of birth.
Detailed description
* Type of study: Randomized clinical trial * Primary objective: To establish the effectiveness of PFC in reducing hypoxia and improving cardiac output compared to immediate postintubation clamping in newborns with CDH. To establish the safety and feasibility of PFC after pulmonary recruitment achieved post intubation. * Secondary objectives: describe the evolution of patients with CDH 24 hours after birth under pre-established conditions. Relate prenatal indices to the subsequent evolution of these patients. Describe maternal evolution and postpartum complications. * Population: Patients who attend the Fetal Diagnosis and Treatment program of Garrahan Children's Hospital and undergo prenatal diagnosis of CDH are possible candidates. The study will be carried out in the Neonatal Intensive Care Unit of said hospital. * Scope of the study: Garrahan Children's Hospital is a level 3 B pediatric hospital and national referral center located in Autonomous City of Buenos Aires, Argentina. Center that receives neonates with CDH referred from all over the country as well as from other countries in the region and carries out the relevant training for equal reception. * Block randomization: will be carried out on the same day, 2 hours before entering the delivery room * Intervention: Immediately after birth, the newborn will be placed on a mobile table, made to received these patients in the delivery room, at the level of the mother's womb, leaving the umbilical cord intact, intubated and gently ventilated (positive inspiration pressure (PIM) 15/25 - positive end expiratory pressure (PEEP)4 - fraction of inspired oxygen inspired oxygen fraction (FiO2) 50%), until saturation \>85% and heart rate (HR) \>100 or 10 timed minutes pass, whichever occurs first, the umbilical cord will be clamped and continued with the usual reception steps in accordance with the unit´s CDH reception protocol. * Sample size: To calculate the sample size, a prevalence of hemodynamic alterations of 60% was considered in the first 24 hours of life of patients with CDH, following unit statistics and the aforementioned bibliography. The estimated sample size with a relative reduction of 50%: reduction from 60% to 30% of hemodynamic alterations - Power of 80% - Two-tailed test - alpha 5%. 40 patients required in each branch.
Interventions
Immediately after birth, the newborn with prenatal diagnosis of CDH will be placed on a mobile table, made to receive these patients in the delivery room, at the level of the mother's womb, leaving the umbilical cord intact and intubated. The patient will be gently ventilated (PIM 15/25 - PEEP 4 - Fio2 50%), until saturation \>85% and HR\>100 or 10 timed minutes have elapsed, whichever occurs first, the umbilical cord will be clamped.
Sponsors
Study design
Eligibility
Inclusion criteria
* Prenatal diagnosis of congenital diaphragmatic hernia * gestational age \>34 weeks * Informed consent signed by the patient's parents
Exclusion criteria
* Multiple gestation * Major malformation or fetal genetic anomaly diagnosed in the prenatal stage * Emergency cesarean section or maternal condition that prevents the approach * Lack of informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Hemodynamic deterioration in the first 24 hours of life | 24 hours of life | Hemodynamic deterioration in the first 24 hours of life (meeting 3 of 4 of the following criteria or entry to extracorporeal membrane oxygenation (ECMO) or Death). 1. Pre/post ductal saturation difference \>10% 2. Oxygenation index (IO) \>20 3. mean arterial pressure \< Percentile 50 or inotrope requirement 4. Lactic acid \>3 mmol/l |
| complete delivery according group | delivery | Complete the protocol in the delivery room pre-established according to randomization (yes/no) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| near-infrared spectroscopy (Nirs) on the first day | 2 - 4 hours and 24 hours of life | Cerebral and somatic NIRS |
| lung volumen | from 26 to 32 weeks of gestational age | lung volumen in RMI |
| Intubation time | From delivery to intubation | Time to intubation (minutes, seconds) |
| Cord clamping time | from delivery to cord clamping | Cord clamping time (minutes, seconds) |
| Advance resuscitation need on delivery room | from delivery to 30 minutes of life | Requirement for advanced resuscitation (yes/no) (compressions, drugs, hypothermia) |
| Time to reach heart rate (HR) >100 | from delivery to 30 minutes of life | Time to reach HR \>100 (minutes, seconds) |
| Time to reach saturation (SAT) >85% | from delivery to 30 minutes of life | Time to reach SAT \>85% (minutes, seconds) |
| Cord PH value | inmediatly after cord clampping | cord ph value |
| Cord lactic acid value | inmediatly after cord clampping | cord lactic acid value in mmol/l |
| saturation at 10 minutes | 10 minutes of life | pre and post ductal saturation % |
| Arterial pressure at 10 minutes | 10 minutes of life | mean arterial tension in mmhg |
| placenta abruption | 30 minutes of life | Time for placental abruption (minutes, seconds) |
| Mother arterial tension after delivery | 10 minutes after delivery | mothers arterial mean tension after delivery in mmhg |
| Uterotonic use | 30 minutes after delivery | uterotonics use on mothers after delivery (yes/no) |
| Evolution of patient Blood preassure (BP) | 2 - 4 hours and 24 hours of life | Blood pressure in mmhg |
| Evolution of patient inotropes required | 2 - 4 hours and 24 hours of life | Inotrope requirement (yes/no) |
| Inhaled nitric oxide (NOi) requirement | 2 - 4 hours and 24 hours of life | NOi requirement (yes/no) |
| ventilation requirements on the first day | 2 - 4 hours and 24 hours of life | Ventilatory mode / mean airway pressure (MAP)/ FIo2 % |
| Oxygenation on the first day | 2 - 4 hours and 24 hours of life | Partial arterial pressure of oxygen (PaO2) mmhg |
| Oxygenation index (OI) on the first day | 2 - 4 hours and 24 hours of life | OI |
| B natriuretic peptide (BNP) on the first day | 24 hours of life | B natriuretic peptide (BNP) |
| PH value on the first day | 6 and 24 hours of life | echocardiographic pulmonary hypertension PH (\<50% of systemic pressure, between 50-80% of systemic pressure, between 80 and 100% of systemic pressure, systemic, suprasystemic) |
| cardiac malformations | 6 hours of life | cardiac malformation (yes/no) |
| Mortality | through study completion, an average of 1 year | Mortality (yes/no) |
| Admission to ECMO | through study completion, an average of 1 year | Admission to ECMO after the first 24 hours (yes/no) |
| Mcgoon | from 26 to 32 weeks of gestational age | Mcgoon Index in fetal echocardiogram |
| maternal hematocrit | 1 day before delivery | maternal hematocrit in gr/dl |
| Gestational age at diagnosis | 1st day of life | Gestational age at diagnosis of CDH in weeks |
| Lung heart rate index observed/expected LHR O/E | from 26 to 32 weeks of gestational age | lung heart rate index observed/expected (LHR O/E) |
| liver in thorax | from 26 to 32 weeks of gestational age | liver in thorax (yes/no) and % |
| stomach herniation | from 26 to 32 weeks of gestational age | stomach herniation (yes/no) and % |
Other
| Measure | Time frame | Description |
|---|---|---|
| Patent ductus arteriosus (PAD) on the first day (size) | 6 and 24 hours of life | Patent ductus arteriosus (PAD): size in milimeters |
| Patent ductus arteriosus (PAD) on the first day (gradient) | 6 and 24 hours of life | Patent ductus arteriosus (PAD): gradient |
| Patent ductus arteriosus (PAD) on the first day (shunt direction) | 6 and 24 hours of life | Patent ductus arteriosus (PAD): shunt direction |
| Patent foramen ovale (PFO) on the first day (shunt direction) | 6 and 24 hours of life | Patent foramen ovale (PFO): shunt direction. |
| Right ventricle (RV) on the first day diameter | 6 and 24 hours of life | Right ventricle (RV): RV diameter in milimeters |
| Right ventricle (RV) on the first day TAPSE | 6 and 24 hours of life | Right ventricle (RV): TAPSE |
| Tricuspide Insufitienty | 6 and 24 hours of life | tricuspide insufitienty |
| Right ventricle funtion | 6 and 24 hours of life | Right ventricle global disfuntion : no, mild, moderate or severe |
| Left ventricle (LV) on the first day (eccentricity index) | 6 and 24 hours of life | Left ventricle (LV): eccentricity index |
| Left ventricle (LV) on the first day (ejection fraction) | 6 and 24 hours of life | Left ventricle (LV): ejection fraction (EF) |
| Left ventricle (LV) on the first day global funtion | 6 and 24 hours of life | Left ventricle (LV) global disfuntion : no, global disfuntion : no, mild, moderate or severe |
| Interventricular septum (IS) on the first day | 6 and 24 hours of life | Interventricular septum: configuration |
| Pulmonary hypertation grade on the first day | 6 and 24 hours of life | Pulmonary hypertation: no, mild, moderate or severe |
| Associated malformations | 24 hours of life | Associated malformations (yes/no), which |
| Chromosomopathy or genetic alteration | through study completion, an average of 1 year | Chromosomopathy or genetic alteration (yes/no), which |
| Hyperbilirubinemia | From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months | Hyperbilirubinemia requiring phototherapy or exchange transfusion (yes/no) |
| Early sepsis | From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months | Early sepsis (yes/no) |
| Omphalitis | From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months | Omphalitis (yes/no) |
| CDH surgery | From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months | CDH surgery (yes/no), days of life |
| Surgical classification | From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months | Surgical classification of CDH (a-b-c-d) |
| Days in neonatal intensive care unit (NICU) | From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months | Days in NICU |
| baby weight | 30 minutes of life | Weight in grams |
| maternal age | through study completion, an average of 1 year | maternal age during pregnancy |
| maternal history | through study completion, an average of 1 year | maternal pathological history during pregnancy (yes/no) |
Countries
Argentina